Society Of Nuclear Medicine Heads To Toronto For 56th Annual Meeting

Main Category: Radiology / Nuclear Medicine
Also Included In: Conferences;  MRI / PET / Ultrasound
Article Date: 05 Mar 2009 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

SNM recently received a warm greeting as it prepares to head north to Canada for its 56th Annual Meeting for nuclear medicine and molecular imaging.

In a letter welcoming SNM to Canada later this year, Prime Minister Stephen Harper, PC, MP, stated his belief that the importance of molecular imaging to the future practice of medicine is undeniable. "It is heartening to know that your efforts are paving the way for a more effective and efficient level of patient care," he said.

For instance, more than 20 million people require molecular imaging or nuclear medicine procedures each year. These procedures include PET/CT scans - commonly used to diagnose and monitor treatment in patients with cancer, and neurological and cardiovascular diseases, including Alzheimer's disease, stroke, and cardiac events.

The prime minister expressed his pleasure at serving as the host country for an event focused on molecular imaging and therapy that "gives researchers and practitioners a forum in which to exchange information about the newest and most promising advances in the field."

Toronto Mayor David Miller welcomed SNM to his city, acknowledging SNM's international reputation as a leader in nuclear medicine and molecular imaging and the annual meeting as "an important opportunity for professionals in the medical field to meet and discuss research and current trends, as well as network with friends and colleagues."

Mayor Miller added that, as home to the Discovery District - a research park with Canada's largest concentration of research institutes and business support services, as well as world-renowned medical researchers - Toronto is an excellent host city for such a meeting.

SNM's Annual Meeting is the world's largest event focused exclusively on the latest developments in molecular imaging. More than 6,000 attendees from around the world will share research, learn about the latest breakthroughs and trends, and discuss important issues in the field that have been making news. More than 180 exhibiting companies will take part in the premier conference.

Source: Amy Shaw
Society of Nuclear Medicine